|
Therapy Area
High blood pressure.
|
|
In phase
Early preclinical optimization phase. |
Competitive edge
Blood pressure reduction in combination with potential organ protective properties on heart and kidney. |
Project data
- Three highly potent series of renin inhibitors with advantageous pharmacokinetic properties.
|
|
|
|
|